In melanoma cells with active melanogenesis, induction of depigmentation with a melanin synthesis inhibitor restores melanoma cell sensitivity to RIPK1/RIPK3/MLKL-mediated necroptosis18. The gene discussed is MLKL; the disease is melanoma.